ReadYourDNA

Lacidipine

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Lacidipine

What it is

Lacidipine is a long-acting calcium channel blocker of the dihydropyridine group: it relaxes the muscle of artery walls, so they widen and blood pressure falls. It is used once daily for high blood pressure in Europe and Asia; it is not marketed in the US. It is sold as Motens and Lacipil, among other names.

How genes come into it

Lacidipine is broken down mainly by CYP3A4. The gene studies on it, from China, looked at the calcium channel gene CACNA1C, the target of the medicine, for how much blood pressure fell. The findings come from a few studies, and there is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Lacidipine. Upload your DNA file to see which of these rows apply to you.

Response (3 findings)

Studies of how well it worked in people carrying a variant.

CACNA1C rs2238032: Genotype TT is associated with increased response to lacidipine, nifedipine or nitrendipine in people with Hypertension as compared to genotypes GG + GT.

CACNA1C rs2239050: Genotype CC is not associated with response to lacidipine, nifedipine or nitrendipine in people with Hypertension as compared to genotype CG.

CACNA1C rs2239128: Allele C is not associated with response to lacidipine, nifedipine or nitrendipine in people with Hypertension as compared to allele T.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Calan (Calcium Channel Blockers)

Calcium Channel Blockers (class) (Calcium Channel Blockers)

Cardene (Calcium Channel Blockers)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com